VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Carbocysteine
Preclinical
Small molecule
T
Tanta University
1
Indications
3
Total Trials
1
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Obstructive Sleep Apnoea
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Obstructive Sleep Apnoea
Preclinical
Completed
Clinical
Trials by Indication
[1]
Bronchiectasis
1 trial
Randomised Open Label Trial of Hypertonic Saline and Carbocisteine in Bronchiectasis (CLEAR)
Completed
·
B
Belfast Health and Social Care Trust
·
Phase 3
·
NCT04140214
·
288 enrolled
Alcoholic Fatty Liver Disease
1 trial
Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients
Recruiting
·
T
Tanta University
·
Phase 2
·
NCT06863376
·
46 enrolled
Obstructive Sleep Apnoea
1 trial
Antioxidant Carbocysteine Treatment in Obstructive Sleep Apnoea Syndrome
Completed
·
G
Guangzhou Institute of Respiratory Disease
·
N/A
·
NCT02015598
·
40 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
3 trial records for Carbocysteine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Carbocysteine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Carbocysteine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Tanta University company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
T
Tanta University
Related News